Neuralert Stroke Monitor Trial
1 other identifier
interventional
1,200
1 country
1
Brief Summary
The Neuralert monitoring system, a non-invasive device worn on each wrist, is designed to provide continuous monitoring and expedited recognition of stroke by identifying asymmetry in the extremities, facilitating patient treatment and improving outcomes. This study is designed to evaluate the safety and effectiveness of the Neuralert Monitor. This study aims to show that the device produces fewer than 2 false alarms per patient per day on average, and that the device detects stroke with a sensitivity significantly greater than a device producing 2 random alerts per day.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable surgery
Started Mar 2026
Typical duration for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2025
CompletedFirst Posted
Study publicly available on registry
January 23, 2026
CompletedStudy Start
First participant enrolled
March 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 15, 2028
April 1, 2026
March 1, 2026
1.8 years
December 8, 2025
March 26, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Efficacy of Device
To show that the sensitivity of the Neuralert Monitor exceeds the specified performance goal, and
through study completion, an average of 2 years
Safety of Device
To show that the mean number of false alarms/patient/day for the Neuralert Monitor is less than the specified performance goal.
through study completion, an average of 2 years
Secondary Outcomes (3)
Length of time to detection of any stroke
through study completion, an average of 2 years
Length of time to detection of stroke by Neuralert
through study completion, an average of 2 years
Number of alerts caused by stroke (PPV)
through study completion, an average of 2 years
Other Outcomes (4)
Number and type of causes of false alarms
through study completion, an average of 2 years
Sensitivity of device
through study completion, an average of 2 years
Number of care visits
through study completion, an average of 2 years
- +1 more other outcomes
Study Arms (1)
Cardiac Surgery Patients
EXPERIMENTALDevice: Neuralert Monitor Device to identify upper extremity asymmetry in patients who are high risk for stroke.
Interventions
The Neuralert monitoring system, a non-invasive device worn on each wrist, is designed to provide continuous monitoring for asymmetry in the extremities, sending an alert to healthcare workers upon identification, thus expediting recognition of stroke.
Eligibility Criteria
You may qualify if:
- Male or female age ≥ 22 years
- Admitted or planned admission to one of the participating hospitals and followed by the Cardiothoracic (CT) Surgery or Vascular Surgery services
- Considered at high risk for stroke while in the hospital based on:
- Interventions or procedures that are high-risk for stroke performed during the hospitalization, which may include:
- Intracardiac surgical or endovascular procedures, including valve replacement
- Ascending aorta or aortic arch surgical or endovascular repair
- Open surgical or endovascular carotid revascularization
- Other cardiac procedures along with a high-risk medical history:
- Age ≥ 80 years
- Prior stroke/ transient ischemic attack (TIA)
- Hypercoagulable state (i.e., prior clotting events attributed to active malignancy or a diagnosed thrombophilia) requiring lifelong anticoagulation
- Severely reduced left ventricular cardiac ejection fraction (i.e., \<30%) or anterior left ventricular wall akinesis
- Atrial fibrillation
You may not qualify if:
- Any medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study
- Baseline preoperative asymmetric upper extremity weakness as assessed by the Investigator, defined as a differential in the NIHSS upper extremity motor score between the two arms of \>0
- Above the wrist amputation
- Unwilling to provide informed consent or no legally authorized representative willing to provide consent if the patient is unable
- Currently imprisoned
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19103, United States
Related Publications (1)
Messe SR, Kasner SE, Cucchiara BL, McGarvey ML, Cummings S, Acker MA, Desai N, Atluri P, Wang GJ, Jackson BM, Weimer J. Derivation and Validation of an Algorithm to Detect Stroke Using Arm Accelerometry Data. J Am Heart Assoc. 2023 Feb 7;12(3):e028819. doi: 10.1161/JAHA.122.028819. Epub 2023 Jan 31.
PMID: 36718858BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2025
First Posted
January 23, 2026
Study Start
March 26, 2026
Primary Completion (Estimated)
January 15, 2028
Study Completion (Estimated)
July 15, 2028
Last Updated
April 1, 2026
Record last verified: 2026-03